2-Aminoimidazoles inhibitors of TGF-beta receptor 1.
Bonafoux, D., Chuaqui, C., Boriack-Sjodin, P.A., Fitch, C., Hankins, G., Josiah, S., Black, C., Hetu, G., Ling, L., Lee, W.C.(2009) Bioorg Med Chem Lett 19: 912-916
- PubMed: 19135364 
- DOI: https://doi.org/10.1016/j.bmcl.2008.11.119
- Primary Citation of Related Structures:  
3FAA - PubMed Abstract: 
The 4-(5-fluoro-6-methyl-pyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-ylamine 3 is a potent and selective inhibitor of TGF-betaR1. Substitution of the amino group of 3 typically led to a slight decrease in the affinity for the receptor and in TGF-beta-inducted PAI-luciferase reporter activity. However, 2-acetamidoimidazoles were identified as attractive candidates for further optimization as a result of their significant activity combined to their superior pharmacokinetic profile.
Organizational Affiliation: 
Abbot Laboratories, 381 Plantation Street, Worcester, MA 01605-2323, USA. dominique.bonafoux@abbott.com